Roche Holding Valuation
| ROG Stock | CHF 255.50 1.60 0.63% |
At this time, the company appears to be overvalued. Roche Holding AG holds a recent Real Value of ₣220.89 per share. The prevailing price of the company is ₣255.5. Our model determines the value of Roche Holding AG from analyzing the company fundamentals such as Operating Margin of 0.32 %, shares outstanding of 693.89 M, and Return On Equity of 0.45 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Roche Holding's price fluctuation is very steady at this time. Calculation of the real value of Roche Holding AG is based on 3 months time horizon. Increasing Roche Holding's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Roche stock is determined by what a typical buyer is willing to pay for full or partial control of Roche Holding AG. Since Roche Holding is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Roche Stock. However, Roche Holding's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 255.5 | Real 220.89 | Hype 253.9 |
The intrinsic value of Roche Holding's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Roche Holding's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Roche Holding AG helps investors to forecast how Roche stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Roche Holding more accurately as focusing exclusively on Roche Holding's fundamentals will not take into account other important factors: Roche Holding Total Value Analysis
Roche Holding AG is at this time forecasted to have takeover price of 270.78 B with market capitalization of 228.28 B, debt of 17.1 B, and cash on hands of 1.82 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Roche Holding fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
270.78 B | 228.28 B | 17.1 B | 1.82 B |
Roche Holding Investor Information
About 40.0% of the company shares are owned by institutional investors. The company recorded earning per share (EPS) of 17.69. Roche Holding AG last dividend was issued on the 16th of March 2023. The entity had 100:1 split on the 4th of May 2001. Based on the key indicators obtained from Roche Holding's historical financial statements, Roche Holding AG is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Roche Holding Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Roche Holding has an asset utilization ratio of 68.03 percent. This indicates that the Company is making ₣0.68 for each dollar of assets. An increasing asset utilization means that Roche Holding AG is more efficient with each dollar of assets it utilizes for everyday operations.Roche Holding Ownership Allocation
Roche Holding owns a total of 693.89 Million outstanding shares. 30% of Roche Holding AG outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Roche Holding Profitability Analysis
The company reported the revenue of 62.8 B. Net Income was 13.93 B with profit before overhead, payroll, taxes, and interest of 47.83 B.About Roche Holding Valuation
Our relative valuation model uses a comparative analysis of Roche Holding. We calculate exposure to Roche Holding's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Roche Holding's related companies.Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. ROCHE GS operates under Drug ManufacturersGeneral classification in Switzerland and is traded on Switzerland Exchange. It employs 100920 people.
8 Steps to conduct Roche Holding's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Roche Holding's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Roche Holding's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Roche Holding's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Roche Holding's revenue streams: Identify Roche Holding's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Roche Holding's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Roche Holding's growth potential: Evaluate Roche Holding's management, business model, and growth potential.
- Determine Roche Holding's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Roche Holding's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Roche Stock Analysis
When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.